Publications of Shreemanta K. Parida
All genres
Journal Article (20)
1.
Journal Article
10, 527 (2019)
Immunometabolic Signatures Predict Risk of Progression to Active Tuberculosis and Disease Outcome. Frontiers in immunology 2.
Journal Article
9 (1), 5208 (2018)
Metabolite changes in blood predict the onset of tuberculosis. Nature Communications 3.
Journal Article
197 (9), pp. 1198 - 1208 (2018)
Four-Gene Pan-African Blood Signature Predicts Progression to Tuberculosis. American Journal of Respiratory and Critical Care Medicine 4.
Journal Article
387 (10035), pp. 2312 - 2322 (2016)
A blood RNA signature for tuberculosis disease risk: a prospective cohort study. Lancet 5.
Journal Article
8 (9), e74080 (2013)
Analysis of Host Responses to Mycobacterium tuberculosis Antigens in a Multi-Site Study of Subjects with Different TB and HIV Infection States in Sub-Saharan Africa. PLoS One 6.
Journal Article
7 (7), e40221 (2012)
Biomarkers of Inflammation, Immunosuppression and Stress with Active Disease Are Revealed by Metabolomic Profiling of Tuberculosis Patients. PLoS ONE 7.
Journal Article
7 (6), e38501 (2012)
Potential of Host Markers Produced by Infection Phase-Dependent Antigen-Stimulated Cells for the Diagnosis of Tuberculosis in a Highly Endemic Area. PLoS ONE 8.
Journal Article
12, 10 (2012)
Potential of novel Mycobacterium tuberculosis infection phase-dependent antigens in the diagnosis of TB disease in a high burden setting. BMC Infectious Diseases 9.
Journal Article
12 (1), pp. 15 - 22 (2011)
Human gene expression profiles of susceptibility and resistance in tuberculosis. Genes and Immunity 10.
Journal Article
14 (6 Suppl. Suppl. 1), pp. S3 - S7 (2010)
Closing the gaps in our understanding of the pathogenesis of tuberculosis. International Journal of Tuberculosis and Lung Disease 11.
Journal Article
22 (3), pp. 374 - 384 (2010)
Novel tuberculosis vaccines on the horizon. Current Opinion in Immunology 12.
Journal Article
15 (3-4 Sp. Iss. Sp. Iss. SI), pp. 148 - 157 (2010)
The quest for biomarkers in tuberculosis. Drug Discovery Today 13.
Journal Article
10 (2), pp. 68 - 69 (2010)
Biomarkers for tuberculosis disease activity, cure, and relapse. Lancet Infectious Diseases 14.
Journal Article
11, 27 (2010)
Biomarker discovery in heterogeneous tissue samples -taking the in-silico deconfounding approach. BMC Bioinformatics 15.
Journal Article
16 (8), pp. 1203 - 1212 (2009)
Immunogenicity of Novel DosR Regulon-Encoded Candidate Antigens of Mycobacterium tuberculosis in Three High-Burden Populations in Africa. Clinical and Vaccine Immunology 16.
Journal Article
9 (3), pp. 162 - 172 (2009)
Biomarkers for tuberculosis disease activity, cure, and relapse. Lancet Infectious Diseases 17.
Journal Article
4 (3), pp. 219 - 228 (2008)
Tuberculosis in Africa: Learning from pathogenesis for biomarker identification. Cell Host & Microbe 18.
Journal Article
5 (7), 145, pp. 1033 - 1036 (2008)
Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations. PLoS Medicine 19.
Journal Article
9 (5), pp. 623 - 628 (2007)
Tumor necrosis factor is critical to control tuberculosis infection. Microbes and Infection 20.
Journal Article
13 (3), pp. 299 - 303 (2007)
Changing funding patterns in tuberculosis. Nature Medicine